Nuvation Bio Inc. (NUVB)
NYSE: NUVB · IEX Real-Time Price · USD
-0.180 (-5.71%)
Apr 12, 2024, 4:00 PM EDT - Market closed

Nuvation Bio Statistics

Total Valuation

Nuvation Bio has a market cap or net worth of $647.60 million. The enterprise value is $79.64 million.

Market Cap 647.60M
Enterprise Value 79.64M

Important Dates

The next estimated earnings date is Thursday, May 2, 2024, after market close.

Earnings Date May 2, 2024
Ex-Dividend Date n/a

Share Statistics

Nuvation Bio has 218.05 million shares outstanding. The number of shares has increased by 1.00% in one year.

Shares Outstanding 218.05M
Shares Change (YoY) +1.00%
Shares Change (QoQ) +0.03%
Owned by Insiders (%) 27.00%
Owned by Institutions (%) 62.01%
Float 122.88M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.14
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 44.11, with a Debt / Equity ratio of 0.01.

Current Ratio 44.11
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -12.20% and return on invested capital (ROIC) is -16.39%.

Return on Equity (ROE) -12.20%
Return on Assets (ROA) -11.90%
Return on Capital (ROIC) -16.39%
Revenue Per Employee n/a
Profits Per Employee -$1.49M
Employee Count 51
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +78.49% in the last 52 weeks. The beta is 1.19, so Nuvation Bio's price volatility has been higher than the market average.

Beta (1Y) 1.19
52-Week Price Change +78.49%
50-Day Moving Average 2.35
200-Day Moving Average 1.71
Relative Strength Index (RSI) 54.96
Average Volume (30 Days) 1,274,968

Short Selling Information

The latest short interest is 2.82 million, so 1.29% of the outstanding shares have been sold short.

Short Interest 2.82M
Short Previous Month 2.60M
Short % of Shares Out 1.29%
Short % of Float 2.30%
Short Ratio (days to cover) 3.45

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -99.82M
Pretax Income -75.80M
Net Income -75.80M
EBITDA -75.65M
EBIT -75.80M
Earnings Per Share (EPS) -$0.35
Full Income Statement

Balance Sheet

The company has $611.21 million in cash and $4.01 million in debt, giving a net cash position of $607.21 million or $2.78 per share.

Cash & Cash Equivalents 611.21M
Total Debt 4.01M
Net Cash 607.21M
Net Cash Per Share $2.78
Equity / Book Value 605.12M
Book Value Per Share 2.78
Working Capital 602.46M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$68.00 million and capital expenditures -$55,000, giving a free cash flow of -$68.05 million.

Operating Cash Flow -68.00M
Capital Expenditures -55,000
Free Cash Flow -68.05M
FCF Per Share -$0.31
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.00%
Shareholder Yield -1.00%
Earnings Yield -11.04%
FCF Yield -9.91%

Analyst Forecast

The average price target for Nuvation Bio is $6.60, which is 122.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.60
Price Target Difference 122.22%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 5.10%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 2